genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Respiratory diseases

Respiratory Bacteria “Talk” Immune System into Tolerating Infection
Featured

Respiratory Bacteria “Talk” Immune System into Tolerating Infection

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment
Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

LNPs Deliver Gene-Editing Tools Directly to Lung Stem Cells, Achieve Long-Lasting Correction
Genome Editing

LNPs Deliver Gene-Editing Tools Directly to Lung Stem Cells, Achieve Long-Lasting Correction

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster
Drug Discovery

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

Uncovering the Mechanisms behind Severe Inflammation in Asthma
News

Uncovering the Mechanisms behind Severe Inflammation in Asthma

Allergic Asthma Abated Using CAR T Cell Therapy in Mice
Genome Editing

Allergic Asthma Abated Using CAR T Cell Therapy in Mice

Sanofi Invests over €1 Billion to Create New Bioproduction Capacity in France
Bioprocessing

Sanofi Invests over €1 Billion to Create New Bioproduction Capacity in France

ASGCT 2024: David Liu Touts Rapid Evolution of Gene-Sized Programmable Editing Technologies
Genome Editing

ASGCT 2024: David Liu Touts Rapid Evolution of Gene-Sized Programmable Editing Technologies

ASGCT 2024: SalioGen’s Nonviral In Vivo Gene Insertion Technology Takes Preclinical Strides
Drug Discovery

ASGCT 2024: SalioGen’s Nonviral In Vivo Gene Insertion Technology Takes Preclinical Strides

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop
Drug Discovery

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

123...78Page 1 of 78

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up